pain

Paingone Plus TENS Pen Featured in 2026 Consumer Report Examining FDA Clearance Status, TENS Pain Therapy Research, and Portable Pain Relief Device Verification

Tukwila, WA, March 05, 2026 (GLOBE NEWSWIRE) -- This report examines publicly available marketing statements and published research literature. Where…

2 weeks ago

The world’s largest brain research prize awarded for groundbreaking discoveries on how we sense touch and pain

The Brain Prize 2026 is awarded to Professors David Ginty (US) and Patrik Ernfors (Sweden) for their pioneering discoveries on…

2 weeks ago

Thermobalancing therapy emerges as drug-free option for BPH, chronic prostatitis, back pain and kidney stones

Oxford, UK, Feb. 21, 2026 (GLOBE NEWSWIRE) -- Therapeutic Dr Allen’s Devices are designed to treat different chronic health conditions,…

3 weeks ago

Tonix Pharmaceuticals Presented Phase 3 RESILIENT Data on TONMYA (Cyclobenzaprine HCl Sublingual Tablets) at the 2026 Non-Opioid Pain Therapeutics Summit

TONMYA demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT study Unique sublingual formulation designed…

2 months ago

Heal N Soothe (Updated): Does It Work For Chronic Pain?

New York City,, Jan. 01, 2026 (GLOBE NEWSWIRE) -- In 2026, Millions of people suffer from chronic back and joint…

3 months ago

The Facial Pain Association (FPA) Highlights Trigeminal Neuralgia and the Facial Pain Community during Facial Pain Awareness Month

SUWANEE, Ga., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Throughout October, the Facial Pain Association (FPA) commemorates Facial Pain Awareness Month…

6 months ago

Novartis Leqvio shows statistically significant and clinically meaningful early LDL-C goal achievement with less muscle pain

V-DIFFERENCE is first study to show that Leqvio prioritized after statins helps more patients achieve guideline low-density lipoprotein cholesterol (LDL-C)…

7 months ago

Lexicon to Present Patient-reported Data on Diabetic Peripheral Neuropathic Pain (DPNP) at the 7th Annual Meeting of the American Society of Pain and Neuroscience (ASPN 2025)

Patient insights informed the development of pilavapadin, Lexicon’s investigational, novel, non-opioid treatment for people suffering from DPNP July 18, 2025…

8 months ago